Dressed to Kill--Second Edition: The Link Between Breast Cancer and Bras, Paperback/Sydney Ross Singer

Descriere

In 1995 the first edition of Dressed to Kill: The Link Between Breast Cancer and Bras revealed the disturbing results of a study that showed a notable correlation between the wearing of bras and the incidence of breast cancer. The women studied who wore bras 24 hours a day were 125 times more likely to have breast cancer compared to bra-free women. Instead of experiencing interest in their research, Sydney Ross Singer and Soma Grismaijer were subjected to a barrage of mercurial assaults. Industry representatives refused to consider the results and dismissed the book out of hand. Mr. Singer even became the target of personal scrutiny. The American Cancer Society took the unusual step of issuing statements of absolute condemnation that were devoid of scientific methodology. The authors had clearly upset the status quo. But despite the continuous attacks, the evidence would not disappear. The authors were determined to get their message out. They were emboldened by people who contacted them from around the world with messages of support. New studies and research emerged that was consistent with their own research. So much so that it became clear that an updated book was needed. So vociferous are the opponents of this theory that the publisher received threats if they proceeded with publication of the book. The details of this incident are included in the book's Foreword. The second edition of Dressed to Kill The Link Between Breast Cancer and Bras (Square One) has been updated to include: Normal 0 false false false EN-US X-NONE X-NONEAdditional references to historical awareness of the bra-cancer link Advice from British Medical Association that bras are the leading cause of breast pain andrequests for breast reduction surgery Numerous additional supportive studies not included in the first edition A 1996 follow-up study by the authors in Fiji Relevant research from New Zealand and Australia Examples of industry resistance to the bra-cancer link since the release of the first ed